Epidemiology and clinical characteristics of childhood parapneumonic empyemas;Épidémiologie et caractéristiques cliniques des complications suppuratives des pneumonies de l'enfant

Archives de Pediatrie

Volumn 14, Issue 11, 2007, Pages 1298-1303

  Desrumaux, A ^a   Francois P ^a   Pascal, C ^a   Cans, C ^b   Croize J ^a   Gout, J P ^c   Pin, I ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Service d'Information et d'Informatique Médicale   (France)

^c Service de pédiatrie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CORTICOSTEROID;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EMPYEMA; FEMALE; HOSPITALIZED CHILD; HUMAN; INFANT; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PLEURA EMPYEMA; POPULATION RESEARCH; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; ABSCESS; BACTERIAL PNEUMONIA; CLINICAL TRIAL; COMMUNICABLE DISEASE; FRANCE; MICROBIOLOGY; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ABSCESS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EMPYEMA, PLEURAL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES;

EID: 35748944507     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2007.06.008     Document Type: Article

References (30)

1. Hardie W., Bokulic R., Garcia V.F., et al. Pneumococcal pleural empyemas in children. Clin. Infect. Dis. 22 (1996) 1057-1063
2. Byington C.L., Spencer L.Y., Johnson T.A., et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin. Infect. Dis. 34 (2002) 434-440
3. Tan T.Q., Mason Jr. E.O., Wald E.R., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110 (2002) 1-6
4. Buckingham S.C., King M.D., and Miller M.L. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr. Infect. Dis. J. 22 (2003) 499-504
5. Schultz K.D., Fan L.L., Pinsky J., et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113 (2004) 1735-1740
6. Rees J.H.M., Spencer D.A., Parikh D., et al. Increase in incidence of chilhood empyema in West Midlands, UK. Lancet 349 (1997) 402
7. Gupta R., and Crowley S. Increasing paediatric empyema admissions. Thorax 61 (2006) 179-180
8. Eastham K.M., Freeman R., Kearns A.M., et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59 (2004) 522-525
9. Deiros-Bronte L., Baquero-Artigao F., Garcia-Miguel M.J., et al. Derrame pleural paraneumonico: revision de 11 anos. An. Pediatr. (Barc.) 64 (2006) 40-45
10. Weil-Olivier C., Levy C., Marguet C., et al. Enquête rétrospective multicentrique sur les pleuropneumopathies infectieuses de l'enfant en France. Arch. Pediatr. 12 (2005) 823-826
11. Byington C.L., Samore M.H., Stoddard G.J., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain West: emergence of nonvaccine serogroups. Clin. Infect. Dis. 41 (2005) 21-29
12. ®) contre les infections invasives à pneumocoque : bénéfice attendu pour les enfants en France. Arch. Pediatr. 11 (2004) 843-853
13. Lahti E., Mertsola J., Kontiokari T., et al. Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children. Eur. J. Clin. Microbiol. Infect. Dis. 25 (2006) 783-789
14. Kaplan S.L., Mason Jr. E.O., Wald E., et al. Six years multicenter surveillance of invasive pneumococcal infections in children. Pediatr. Infect. Dis. J. 21 (2002) 141-147
15. Hausdorff W.P., Bryant J., Paradiso P.R., et al. Which pneumococal serogroups cause the most invasive disease: implication for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30 (2000) 100-121
16. Al-Kaabi N., Solh Z., Pacheco S., et al. A comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr. Infect. Dis. J. 25 (2006) 1008-1012
17. Pons-Catalano C., Vallet C., Lorrot M., et al. Pneumonies communautaires et infection grippale. Arch. Pediatr. 10 (2003) 1056-1060
18. O'Brien K.L., Walter M.I., Sellman J., et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis. 30 (2000) 784-789
19. Thumerelle C., Santos C., Morillon S., et al. Facteurs de risque de survenue des pleuropneumopathies bactériennes en pédiatrie. Arch. Pediatr. 12 (2005) 827-829
20. Tan T.Q., Mason Jr. E.O., Barson W.J., et al. Clinical characteristics and outcome of children with pneumonia attribuable to penicillin-susceptible and non-susceptible Streptococcus pneumoniae. Pediatrics 102 (1998) 1369-1375
21. Zerr D.M., Alexander E.R., Duchin J.S., et al. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103 (1999) 783-790
22. Lesko S.M., O'Brien K.L., Schwartz B., et al. Invasive group A streptococcal infection and non steroidal antiinflammatory drug use among children with primary varicella. Pediatrics 107 (2001) 1108-1115
23. Endres S., Whitaker R.E., Ghorbani R., et al. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 β and tumor necrosing factor-α ex vivo. Immunology 87 (1996) 264-270
24. Spinas G.A., Bloesch D., Keller U., et al. Pretreatment with ibuprofen augments circulating necrosing factor-α, interleukine-6, and elastase during acute endotoxinemia. J. Infect. Dis. 163 (1991) 89-95
25. Barnes N.P., Hull J., and Thomson A.H. Medical management of parapneumonic pleural disease. Pediatr. Pulm. 39 (2005) 127-134
26. Colice G.L., Curtis A., Deslauriers J., et al. Medical and surgical treatment of parapneumonic effusions: an evidence based guideline. Chest 118 (2000) 1158-1171
27. Cohen G., Hjortdal V., Ricci M., et al. Primary thoracoscopic treatment of empyema in children. J. Thorax Cardiovasc. Surg. 125 (2003) 79-83
28. Thomson A.H., Hull J., Kumar M.R., et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 57 (2002) 343-347
29. Yao C.T., Wu J.M., Liu C.C., et al. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest 125 (2004) 566-571
30. Balfour-Lynn I.M., Abrahamson E., Cohen G., et al. BTS guidelines for the management of pleural infection in children. Thorax 60 Suppl 1 (2005) i1-i21